Results 131 to 140 of about 25,343,255 (333)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

The Emergence of Non-Traditional Cooperative Structures: Public and Private Policy Issues [PDF]

open access: yes
This paper examines new agricultural cooperative organizational models from an ownership rights perspective. We argue that new cooperative organizational models differ in the way ownership rights are assigned to the economic agents tied contractually to ...
Chaddad, Fabio Ribas, Cook, Michael L.
core   +1 more source

The organization as an information system: signposts for new investigations [PDF]

open access: yes, 1999
This paper focuses on the question of how industry should adapt to today's information environment. It is proposed that businesses should look to long-standing organizations such as the church and government for an appropriate information model.
Barlow, HA, Burke, ME
core  

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Collaborating for Gender Equity in Christian Education

open access: yes, 2020
This essay addresses the importance of teachers promoting gender equity. It explores potential causes for gender discrimination in Christian institutions including double standards, unequal representation, organizational culture and similarity attraction.
Castellon, Adrienne R., Sowerby, Stacy
core  

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

‘And if I don’t want to work like an artist...?’ How the study of artistic resistance enriches organizational studies [PDF]

open access: yes, 2013
An increasing number of artists, from theatre makers to painters, critique recent aesthetic developments in organizational life.* One of their topics is the relation between work and freedom, as employees, like artists, are required to bring fully into ...
Biehl-Missal, B
core  

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

The Clustering of Organizational Innovation: Developing Governance Models for Vertical Integration [PDF]

open access: yes
This case explores a cluster of firms that emerged sharing a particular ownership structure. Typically, clusters are thought of as interrelated firms that produce similar products and services.
Burress, Molly J.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy